These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 27459671

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C, Inestrosa NC.
    J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
    [Abstract] [Full Text] [Related]

  • 23. Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau.
    Zhang H, Chen W, Li Z, Huang Q, Wen J, Chang S, Pei H, Ma L, Li H.
    J Ethnopharmacol; 2024 Jan 10; 318(Pt B):116985. PubMed ID: 37532075
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Melatonin Induction of APP Intracellular Domain 50 SUMOylation Alleviates AD through Enhanced Transcriptional Activation and Aβ Degradation.
    Liu YC, Hsu WL, Ma YL, Lee EHY.
    Mol Ther; 2021 Jan 06; 29(1):376-395. PubMed ID: 32950104
    [Abstract] [Full Text] [Related]

  • 28. [Alzheimer disease: cellular and molecular aspects].
    Octave JN.
    Bull Mem Acad R Med Belg; 2005 Jan 06; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [Abstract] [Full Text] [Related]

  • 29. Upregulation of PGC-1α expression by Alzheimer's disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP.
    Robinson A, Grösgen S, Mett J, Zimmer VC, Haupenthal VJ, Hundsdörfer B, Stahlmann CP, Slobodskoy Y, Müller UC, Hartmann T, Stein R, Grimm MO.
    Aging Cell; 2014 Apr 06; 13(2):263-72. PubMed ID: 24304563
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
    Manczak M, Reddy PH.
    Hum Mol Genet; 2012 Dec 01; 21(23):5131-46. PubMed ID: 22926141
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T, Maekawa S, Kimura T, Takashima A, Tomiyama T, Mori H.
    Acta Neuropathol; 2014 May 01; 127(5):685-98. PubMed ID: 24531886
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y, Sun J, Hon S, Nylander AN, Xia W, Feng Y, Wang X, Lemere CA.
    J Neurosci; 2010 Jun 16; 30(24):8180-9. PubMed ID: 20554868
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.